A Peek into the Future – Repair and Replacement of the Mitral and Tricuspid Valves with the Edwards Portfolio: On-demand Programme
Published: 19 March 2021
16m 23sPart 2 The PASCAL Platform – Successfully and Confidently Treat MR Peter Lüdike
14m 31sPart 3 The PASCAL Ace Implant System – Therapy to Successfully Treat TR Philipp Lurz
12m 39sPart 4 Looking into the Future – Valve Replacement with the EVOQUE Ralph Stephan von Bardeleben
This on-demand version of the broadcast 'A Peek into the Future – Repair and Replacement of the Mitral and Tricuspid Valves with the Edwards Portfolio' comprises an internationally-respected faculty, as they review the PASCAL platform focusing on the recently CE mark approved PASCAL Ace implant system for the treatment of mitral and tricuspid regurgitation. Under the stewardship of programme Chair, Prof Nicolas van Mieghem, Erasmus Medical Center, Rotterdam, this programme examines the role of the PASCAL platform the the treatment of MR, the PASCAL Ace Implant System in the treatment of TR, valve replacement with EVOQUE, and includes a live procedure from Heidelberg University Hospital to best enhance practical learnings.
Pipeline products for tricuspid transcatheter replacement from Edwards Lifesciences will be shown and briefly discussed.
- Outline the pathogenic nature and clinical risk of extended exposure to elevated LDL-C
- Describe the clinical challenges in achieving guideline-based LDL-C goals
- Compare and contrast LDL-C lowering therapies
- Interventional Cardiologists
- General Cardiologists
- Heart Failure Specialists
More from this programme
Introduction – A Peek into the Future Repair and Replacement of the Mitral & Tricuspid Valves With the Edwards Portfolio
The PASCAL Platform – Successfully and Confidently Treat MR
The PASCAL Ace Implant System – Therapy to Successfully Treat TR
Looking into the Future – Valve Replacement with the EVOQUE
Case – PASCAL Ace Implant System for the Treatment of TR
Head, HFU Centre, Department of Cardiology, Heidelberg University Hospital, Germany
Prof Philip Raake is a senior physician who leads the HFU centre at the Department of Cardiology at Heidelberg University Hospital. He also runs the Interventional HF programme.
Prof Philip Raake attended medical school at the Ludwig-Maximilians University in Munich. Between 2006 and 2008, Prof Raake worked at the Center for Translational Medicine, under the direction of Prof Walter Koch, at the Thomas Jefferson University, Philadelphia.
In 2008 Prof Raake returned to Germany, where his established the first university Advanced Heart Failure Unit in Germany focusing on optimised care in advanced HF. He has authored or co-authored several papers in leading peer-reviewed journals on HF basic molecular mechanisms, and clinical aspects of advanced HF. He serves on several working groups for the German Society for Cardiology and the German Federal Physicians Association.